Rubbish Check
Daily Mail Money · 1 October 2026
source“Boots set to be bought by billionaire Canadian family in fresh blow to London stock market”
R5/ 10
Selective
Rubbish Rating — 1 = base fact, 10 = pure rubbish
12345678910
In short
Rubbish Talk rates the Daily Mail's claim that Boots is "set to be bought" by the Weston family a 5/10, because the article's own reporting admits "no final decisions have been made" on a deal the headline presents as settled.
The Verdict
Selective. The underlying report checks out against the FT and multiple corroborating outlets, but the headline's certainty ("set to be bought") outruns the article's own hedging, which states a deal "could" land next week and explicitly flags that nothing is final. Other outlets covering the same FT story used softer, more accurate verbs like "closing in on" and "edging closer to."
What actually happened
The Financial Times reported that Sycamore Partners, the private equity owner of Boots, is in talks to sell the chain to the Weston family's Wittington Investments rather than pursue a long-mooted London stock market listing. A deal could be reached within days, but as the Daily Mail's own text states, "no final decisions have been made."
Key facts
- A sale could see Boots valued at around £6.8billion, according to The Financial Times, dashing hopes of an initial public offering, although no final decisions have been made.
- Other outlets reporting the same FT story cite a £7 billion figure, and US-focused outlets cite $9-10 billion, showing the valuation is still fluid and report-dependent rather than fixed.
- In June, Australian pharmacists Sigma Healthcare, who had held 'preliminary discussions' with Boots, pulled out of talks, rekindling hopes of a float. The IPO was a revived hope, not a locked-in plan, which the "blow" framing elides.
- The Westons sold Selfridges for £4billion in 2022, giving context for their UK retail track record and buyer credibility.
- Boots last year saw annual sales rise 3.2 per cent to £7.5billion, boosted by strong demand for its beauty products and weight-loss jabs, the underlying commercial strength that makes it an attractive target either way.
What to watch for
Watch whether Sycamore actually signs a deal "next week" as floated, or whether talks stall like the Sigma Healthcare approach did in June. If a deal is announced, watch which valuation figure sticks, since reports already range from £6.8bn to roughly $10bn (around £7.4bn). A confirmed sale would also settle whether Stefano Pessina's 44% stake holders back the Weston bid or hold out for a float.
About this scoreThe R-Score is Rubbish Talk's editorial opinion on how far a headline's framing sits from what the underlying facts support. It is a judgement about presentation and emphasis, not an allegation that any outlet has acted dishonestly. Every figure we rely on is linked under Receipts so you can check it yourself.
